News
What's happening in Alzheimer's care, research funding, and treatment — summarized simply, each item linked to the original reporting.
Free to read, “May need a subscription” and “Archived copy”: what they mean
Whether an article is free to read is a guess, not a test of your access. Each item is one of three:
- No label: free to read (341 of 400). The publisher’s page marks it free, or the outlet publishes free to read: Medical Xpress, ScienceDaily, NIH (incl. NIA and PMC), Alzheimer's Association, Alzheimer's News Today, NPR, Alzheimer's Disease International, or a .gov site.
- May need a subscription (15 of 400). The publisher’s own page marks the article as not free to read, or — when the page says nothing — the outlet sells subscriptions: The New York Times, STAT, Scientific American, The Washington Post, The Wall Street Journal, Financial Times, The Economist, Bloomberg, The Atlantic, The New Yorker, Wired, Los Angeles Times, The Boston Globe, The Times, The Telegraph, New Scientist, Endpoints News, Science. Each badge says which.
- “Free to read? Not known” (44 of 400). The outlet is on neither list and its page said nothing. We do not call these paywalled.
Archived copy links go to a copy the Internet Archive (web.archive.org) saved, dated the day it was saved. We show one only where the Internet Archive reported a working saved copy when we checked; an archived copy of a subscription article sometimes shows only its opening. 288 of 400 items have one.
Alzheimer’s may trick the brain into erasing its own memories
Alzheimer’s may destroy memory by flipping a single molecular switch that tells neurons to prune their own connections. Researchers found that both amyloid beta and inflammation converge on the same receptor, triggering synapse loss. …
Read at ScienceDaily → Archived copy (26 Jan 2026), Internet ArchiveThis one gene may explain most Alzheimer’s cases
Alzheimer’s may be driven far more by genetics than previously thought, with one gene playing an outsized role. Researchers found that up to nine in ten cases could be linked to the APOE gene — even including a common version once considered neutral. …
Read at ScienceDaily → Archived copy (23 Sep 2026), Internet ArchiveAlzheimer's disease can be evaluated with brain stimulation, finds study
As individuals with Alzheimer's disease (AD) move from the mild cognitive impairment stage to moderate and severe dementia, complex awareness deteriorates although lower-level sensory awareness is relatively maintained. …
Read at Medical Xpress → Archived copy (22 Jan 2026), Internet ArchiveHelping people with dementia have a say in their medical care
A new resource is helping people with dementia speak to their doctors and health care professionals about their medicines with more confidence.
Why it matters: A new resource helps people with dementia communicate with doctors and health care professionals about their medicines with more confidence.
Read at Medical Xpress → Archived copy (26 Feb 2026), Internet ArchiveEnding dementia stigma could change its trajectory: Cancer's history shows why
At a recent party, another guest, a nurse, asked what I do for a living. I explained that as a health policy researcher, my work focuses on helping health-care systems coordinate care for dementia as effectively as for major conditions like cancer, diabetes or stroke. …
Why it matters: A health policy researcher highlights the need for health-care systems to coordinate dementia care as effectively as major conditions like cancer.
Read at Medical Xpress → Archived copy (22 Jan 2026), Internet ArchiveWhy people with dementia wander—and how families can keep them safe
In June 2025, an elderly woman with dementia went missing in a forested area in Natuna, Indonesia, while tending to her plants. Search and rescue (SAR) teams were deployed to locate her.
Why it matters: Understanding why people with dementia wander can help families keep them safe, especially when individuals go missing in dangerous areas.
Read at Medical Xpress → Archived copy (22 Jan 2026), Internet ArchivePeople with obesity may have a higher risk of dementia
People with obesity and high blood pressure may face a higher risk of dementia, according to a new study published in The Journal of Clinical Endocrinology & Metabolism.
Why it matters: A new study indicates that people with obesity and high blood pressure may face an increased risk of developing dementia.
House and Senate Appropriators Endorse NIH Budget Increase, Reject Trump's Proposed Cuts
Congressional appropriators set the NIH's overall budget at $48.7 billion for FY2026, a $415 million increase over FY2025, rejecting the White House's proposed cuts, while allowing a new multiyear-grant funding strategy to continue that had already resulted in thousands fewer awards to scientists in 2025.
Why it matters: Shows Congress broadly rebuffing proposed NIH cuts that had alarmed the Alzheimer's research community, though changes to multiyear grant funding could still constrain some researchers.
May need a subscription Based on the outlet (STAT), not a check of this article.
Read at STAT News → Archived copy (20 Jan 2026), Internet ArchiveNot all sitting is the same when it comes to brain health
Passive activities such as watching television have been linked to worse memory and cognitive skills, while 'active sitting' like playing cards or reading correlate with better brain health, researchers have found.
Read at Medical Xpress → Archived copy (20 Jan 2026), Internet ArchiveA simple blood test could change how Alzheimer's is diagnosed
A blood test, combined with an ultrathin material derived from graphite, could significantly advance efforts to detect Alzheimer's disease at its very earliest stage, even before symptoms appear.
Why it matters: Combining a blood test with an ultrathin graphite-derived material could advance efforts to detect Alzheimer's disease before symptoms appear.
Read at Medical Xpress →Seniors with dementia being prescribed dangerous mind-altering drugs, study says
Many seniors with dementia are being put at risk by brain-altering medications linked to falls, confusion and hospitalization, a new study says.
Why it matters: Many seniors with dementia are put at risk by brain-altering medications linked to falls, confusion, and hospitalization, according to a new study.
Read at Medical Xpress → Archived copy (17 Jan 2026), Internet ArchiveSuper agers tend to have at least two key genetic advantages, study finds
The gene variant posing the greatest genetic risk of late-onset Alzheimer's disease (AD) is called APOE-ε4. A different variant of the same gene, APOE-ε2, is thought to confer protection against AD.
Read at Medical Xpress → Archived copy (6 Mar 2026), Internet ArchiveExperts provide policy roadmap to reduce dementia risk
A national panel of experts has issued the strongest call yet for the Department of Health and Social Care to overhaul how it approaches dementia prevention…
Why it matters: A national panel of experts has issued a call for the Department of Health and Social Care to overhaul its approach to dementia prevention.
Read at Medical Xpress →Scientists find ‘master regulator’ that could reverse brain aging
Researchers have identified OTULIN, an immune-regulating enzyme, as a key trigger of tau buildup in the brain. When OTULIN was disabled, tau vanished from neurons and brain cells remained healthy. …
Read at ScienceDaily →Safe, low-cost Alzheimer's drug demonstrates efficacy against sickle cell anemia
Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle cell anemia in the future. …
Why it matters: Memantine, a long-approved and cost-effective Alzheimer's drug, shows potential to benefit patients with sickle cell anemia in the future.
Read at Medical Xpress →Depression might signal brain disease risk among seniors
Depression in old age could be an early sign of serious brain disease, a new study says.
Why it matters: A new study indicates that depression in old age might be an early sign of serious brain disease.
New ALS treatment target identified: STAUFEN-1 protein reduction protects brain cells from death
University of Utah researchers at the Pulst-Scoles Laboratory have discovered that reducing levels of the STAUFEN-1 protein can prevent neuron death caused by DNA damage and p53 activation in neurodegenerative diseases.
Why it matters: Reducing STAUFEN-1 protein levels can prevent neuron death caused by DNA damage and p53 activation in neurodegenerative diseases like ALS.
Read at Medical Xpress →Why a life-threatening sedative is being prescribed more often for seniors
When agitated dementia patients wander or shout through the night, families and caregivers understandably feel the need to treat this frightening and potentially dangerous behavior. …
Why it matters: When agitated dementia patients wander or shout at night, families and caregivers seek ways to treat this frightening and potentially dangerous behavior.
Read at Medical Xpress → Archived copy (10 Mar 2026), Internet ArchiveStudy finds ongoing under-diagnosis of high blood pressure in people over 50 in Ireland
High blood pressure becomes more common after age 40, yet new research from The Irish Longitudinal Study on Ageing (TILDA) at Trinity College Dublin shows that many people in Ireland with hypertension are still not optimally diagnosed or treated based on European Guidelines. …
Why it matters: New research shows many people over 50 in Ireland with high blood pressure are still not optimally diagnosed or treated based on European Guidelines.
Read at Medical Xpress → Archived copy (4 Feb 2026), Internet ArchiveMassive brain study reveals why memory loss can suddenly speed up with age
A massive international brain study has revealed that memory decline with age isn’t driven by a single brain region or gene, but by widespread structural changes across the brain that build up over time. …
Read at ScienceDaily → Archived copy (23 Sep 2026), Internet ArchiveA hidden brain signal may reveal Alzheimer’s long before diagnosis
Researchers have discovered a brain activity pattern that can predict which people with mild cognitive impairment are likely to develop Alzheimer’s disease. …
Read at ScienceDaily → Archived copy (18 Sep 2026), Internet ArchiveFDA decision on AXS-05 for Alzheimer’s agitation expected April 30
The U.S. Food and Drug Administration (FDA) granted priority review to an application from Axsome Therapeutics seeking approval of its oral therapy AXS-05 to treat agitation related to Alzheimer’s disease, and expects to decide by April 30, the company said. …
Read at Alzheimer's News Today → Archived copy (1 Jul 2026), Internet ArchiveCMS GUIDE Model: Lessons Learned by an Established Track Program at End of Year One
A review of one Established Track GUIDE Model dementia-care program's first year found 158 patients and caregivers enrolled, over 35% of eligible beneficiaries used respite services, and about 9% disenrolled, often due to death or hospice transition.
Why it matters: Early real-world evidence on how Medicare's new dementia care payment model is working for caregivers, including uptake of respite care, one of its core promised benefits.
Read at Peer-reviewed report (PMC / Innovation in Aging) →Key phospholipid points to potential treatment for vascular dementia
A possible new treatment for impaired brain blood flow and related dementias is on the horizon. Research by scientists at the University of Vermont Robert Larner…
Why it matters: Research by scientists at the University of Vermont Robert Larner points to a potential treatment for impaired brain blood flow and vascular dementia.
Read at Medical Xpress → Archived copy (3 Jan 2026), Internet ArchiveHidden 'switches' in DNA reveal new insights into Alzheimer's disease
A tiny percentage of our DNA—around 2%—contains 20,000-odd genes. The remaining 98%—long known as the non-coding genome, or so-called 'junk' DNA—includes many of the "switches" that control when and how strongly genes are expressed.
Read at Medical Xpress → Archived copy (17 Feb 2026), Internet ArchiveAlzheimer's disease more prevalent in older people than previously thought
New research, published in Nature, has provided the first ever population-based data on the frequency of Alzheimer's disease neuropathological changes (ADNC)—a key causal factor behind the development of dementia…
Why it matters: New research in Nature provides the first population-based data on Alzheimer's disease neuropathological changes, showing higher prevalence in older people than thought.
Plasma p-tau217 can reliably detect preclinical Alzheimer disease
Plasma phosphorylated tau 217 (p-tau217) can reliably detect Alzheimer disease (AD) pathology in the preclinical stage, according to a meta-analysis published online Dec. 1 in JAMA Neurology.
Why it matters: Plasma phosphorylated tau 217 can reliably detect Alzheimer disease pathology in the preclinical stage, according to a meta-analysis.
Engineers decode dementia type using AI and EEG brainwave analysis
Dementia is a group of disorders that gradually impair memory, thinking and daily functioning. Alzheimer's disease (AD), the most common form of dementia, affects about 7.2 million Americans aged 65 and older in 2025. …
Read at Medical Xpress → Archived copy (14 Feb 2026), Internet ArchivePowerful new brain PET scanner is opening new research pathways
At the Yale Positron Emission Tomography (PET) Center, an ultra-high-performance brain-dedicated scanner called the NeuroEXPLORER (NX) is redefining what is possible in brain PET imaging.
Why it matters: The NeuroEXPLORER, an ultra-high-performance brain-dedicated PET scanner at the Yale PET Center, is redefining what is possible in brain PET imaging.
Read at Medical Xpress → Archived copy (6 Feb 2026), Internet ArchiveMiddle-aged brains show capacity for repair when treated with therapeutic intervention
Normal aging is characterized by deficits in the cognitive domains of learning, memory and executive function. Specifically, there are age-related changes in recall of information, speed of processing, visuospatial skills and cognitive flexibility. …
Why it matters: Normal aging brings cognitive deficits in learning, memory, and executive function, but middle-aged brains demonstrate a capacity for repair when treated with therapeutic intervention.
Read at Medical Xpress → Archived copy (29 Dec 2025), Internet ArchiveFollow new items in a feed reader: Atom feed.
Last updated